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Abstract
Multiple sclerosis is a debilitating neuroimmunological and neurodegenerative disease affecting 
more than 400,000 individuals in the United States. Population and family-based studies have 
suggested that there is a strong genetic component. Numerous genomic linkage screens have 
identified regions of interest for MS loci. Our own second-generation genome-wide linkage study 
identified a handful of non-MHC regions with suggestive linkage. Several of these regions were 
further examined using single-nucleotide polymorphisms (SNPs) with average spacing between 
SNPs of approximately 1.0 Mb in a dataset of 173 multiplex families. The results of that study 
provided further evidence for the involvement of the chromosome 1q43 region. This region is of 
particular interest given linkage evidence in studies of other autoimmune and inflammatory 
diseases including rheumatoid arthritis and systemic lupus erythematosus. In this follow-up study, 
we saturated the region with ~700 SNPs (average spacing of 10kb per SNP) in search of disease 
associated variation within this region. We found preliminary evidence to suggest that common 
variation within the RGS7 locus may be involved in disease susceptibility.
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Introduction
Multiple sclerosis (MS [MIM 126200]) is a neurodegenerative autoimmune disease 
characterized by demyelination within the central nervous system (CNS. Demyelination and 
the resulting formation of scar tissue in the CNS impair the saltatory conduction along axons 
that is necessary for normal functioning of nerve impulses. Though little is known about the 
underlying etiology of the disease, MS is a heterogeneous disorder with several 
characteristics common to autoimmune disorders —including polygenic inheritance, 
evidence of environmental exposure, and partial susceptibility conferred by a human 
leukocyte antigen (HLA)-associated gene (Barcellos, et al. 2002). There is also a greater 
prevalence of the disease in women than in men. This inflammatory disorder results from an 
autoimmune response directed against CNS antigens—particularly myelin proteins. Class II 
major histocompatibility complex (MHC) molecules, such as HLA (human leukocyte 
antigen), normally function to bind and present peptide antigens to antigen-specific T cells. 
It is thought that the dysregulation of this process in MS results in damage to the myelin 
sheath, producing the pathophysiological phenotype seen in the disease. Despite the 
degenerative nature of the disease, an affected individual’s lifespan is rarely shortened.
The clinical heterogeneity and complex etiology of MS have been confounding factors for 
genetic studies of the disease. Yet despite these complexities, it is clear that genes play a 
vital role in the susceptibility to MS. Numerous research groups, including our own, have 
conducted genomic linkage screens for MS in an attempt to identify regions that harbor 
disease loci (Akesson, et al. 2002, Ban, et al. 2002, Broadley, et al. 2001, Coraddu, et al. 
2001, Dyment, et al. 2004, Ebers, et al. 1996, Eraksoy, et al. 2003, Haines, et al. 1996, 
Hensiek, et al. 2003, Kenealy, et al. 2004, Kuokkanen, et al. 1997, Sawcer, et al. 1996, 
Sawcer, et al. 2005). Over 70 genomic regions have been investigated, revealing varying 
levels of support. However, the lack of replication of results from these studies has been 
problematic for using linkage to detect loci involved in MS.
The strongest and most consistent finding for linkage to MS is chromosome 6p21.3, the 
location of the MHC containing HLA. Until just recently, the MHC has been the only region 
clearly and consistently demonstrating linkage and association with MS (Haines, et al. 1996, 
Sawcer, et al. 1996, Sawcer, et al. 2005, Yaouanq, et al. 1997). However, the MHC has been 
estimated to account for only 10–50% of the genetic component of MS susceptibility, at 
least in the Caucasian populations of northern European descent (Dyment, et al. 2004, 
Haines, et al. 1998). It appears that the association with the HLA-DRB1*1501 allele 
explains this linkage signal (Barcellos, et al. 2002, Haines, et al. 1998), although this issue 
has been debated (Ligers, et al. 2001). The exact mechanism by which a gene or genes in the 
MHC increase disease risk has yet to be determined, although recent work has sought to 
provide the tools needed to explore this region in greater detail (de Bakker, et al. 2006, 
Horton, et al. 2008). Recent work by our group has identified a strongly associated single-
nucleotide polymorphism (SNP) (rs6897932) in the interleukin-7 receptor α gene (IL7RA), a 
gene located on chromosome 5p13. This SNP introduces a coding change (T244I) that alters 
the ratio of soluble to bound protein (Gregory, et al. 2007). This result was further replicated 
in a genome-wide association study (GWAS) performed by a broader collaborative group of 
investigators (The International Multiple Sclerosis Genetics Consortium (IMSGC)). The 
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GWAS also identified additional replicated associations with variations in other genes 
(including CD25/IL2RA and CD58) (International Multiple Sclerosis Genetics Consortium, 
et al. 2007). The involvement of these genes plus several others (e.g. CLEC16A) are now 
being tested and confirmed in multiple international studies (International Multiple Sclerosis 
Genetics Consortium (IMSGC). 2008, Rubio, et al. 2008, Weber, et al. 2008).
Although genome-wide association studies have now begun, dense SNP follow-up studies of 
narrowed linkage regions are still underway because of their potential for identifying 
additional disease susceptibility genes. The American-French Multiple Sclerosis Genetics 
Group published one of the largest MS genomic linkage screens conducted (Kenealy, et al. 
2004). Follow-up of candidate regions identified in this study entailed genotyping SNPs at 
approximately 1.0 Mb intervals flanking 10 Mb on each side of peak screen SNPs in an 
expanded U.S. dataset (Kenealy, et al. 2006). The 1q43 region not only continued to 
demonstrate evidence for linkage in the follow-up analysis (non-parametric multipoint LOD 
= 2.99), but also generated a narrowed linkage interval when using the ordered subset 
analysis (OSA) method to condition on the other loci (Ghosh, et al. 2000, Hauser and 
Boehnke. 1998, Hauser, et al. 2001, Kenealy, et al. 2006). This narrowed interval is ~7.0 Mb 
for a LOD score cut-off of 1.8 (corresponding to a –2.0 LOD score confidence interval from 
the 3.8 LOD score HLA-based peak) (see Figure 1). Chromosome 1q43 was selected for 
further detailed investigation based on several additional lines of evidence. SNPs in the 1q43 
region have also demonstrated suggestive linkage and/or association in several other MS 
screens conducted in a variety of study populations (Ban, et al. 2002, Broadley, et al. 2001, 
Goedde, et al. 2002, Laaksonen, et al. 2003, Sawcer, et al. 2002). None of these earlier 
studies, which lack the power and marker density of the current generation of genome-wide 
association studies, demonstrate significant evidence for either linkage or association. 
However, they do provide support from independent sample populations of an effect within 
a common region of interest. Another compelling piece of evidence for 1q is linkage to this 
region in studies for the autoimmune diseases rheumatoid arthritis and systemic lupus 
erythematosus, suggesting the potential presence of a gene common to autoimmune 
processes in this region (Gaffney, et al. 1998, Gaffney, et al. 2000, Jawaheer, et al. 2001, 
Jawaheer, et al. 2003, MacKay, et al. 2002, Shai, et al. 1999). Following these lines of 
evidence, we set out to test whether common variation within this region is involved in 
susceptibility to develop multiple sclerosis.
Results
After quality control procedures, 578 SNPs were included in our initial analysis. Using the 
Tagger implementation in the Haploview program we selected 268/578 SNPs, with r2<0.2, 
for inclusion in a multipoint linkage analysis of the narrow interval. These results continue 
to demonstrate considerable evidence for linkage to this region (peak Lod Score 3.42 at 
~238Mb) (Figure 2a). As was analyzed in the initial follow-up (Kenealy, et al. 2006), we 
examined this narrowed interval using the ordered subset analysis (OSA) method to 
condition on the same loci (namely HLA-DRB1*1501 and Chr2) in an attempt to further 
resolve this effect (Figure 2a). The goal of this analysis was to determine if other previously 
suggested linkage regions, within our initial dataset, have a significant effect on the 1q43 
region such that we might be able to identify specific subsets of our sample that may 
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account for the effect within this region. Neither of these conditional analyses demonstrated 
significant differences in lod scores from the overall multipoint analysis, suggesting that 
neither of these two loci can be used to predict families which will demonstrate strong 
evidence for a genetic effect within the 1q43 region.
Finally, as recent genome-wide association studies have found genetic overlap (by way of 
identifying common loci, which are definitively associated with multiple autoimmune-
related disorders) within autoimmune disorders, it is feasible that a gene (or genes) within 
this region of chromosome 1q43 is affecting multiple autoimmune phenotypes (Maier and 
Hafler. 2008). Given the evidence for linkage in other autoimmune diseases, we split our 
dataset into a) families with evidence of additional autoimmune disease (n=100); b) families 
with no evidence of additional autoimmune diseases (n=53); note there were 20 families for 
which a decision could not be made given our available information. While the lod scores 
are generally higher for the families with evidence for multiple autoimmune diseases, this 
difference is not significant (Figure 2b).
Subsequent to the multipoint linkage analysis, we conducted tests of association across the 
578 SNPs. Twelve SNPs demonstrated nominal p-values (p ≤0.05) (Table 1). We then chose 
an additional set of 51 SNPs to be genotyped (using Taqman) in our extended dataset of 831 
multiplex and trio families. These SNPs provide a higher density across regions 
demonstrating either evidence for linkage (based on 2pt lod scores) or association. Analysis 
of these additional SNPs pointed to a region of interest within the RGS7 gene. Two adjacent 
SNPs within the follow-up demonstrated both the highest 2pt lod score (rs4660010, 
lod=3.24) and the most significant association (rs261809, PDT p = 0.01). While none of 
these results survive any sort of multiple comparisons correction, they suggest the need for 
further examination. We then examined the data from the recent IMSGC genome-wide 
association study to determine if there was any evidence for association across this region 
(International Multiple Sclerosis Genetics Consortium, et al. 2007). Several of these SNPs 
demonstrate moderately significant p-values within this same region (Table 2). It should be 
noted that 301 trios in our follow-up dataset (n= 831 families) overlap with the 931 trios 
within the GWAS. While the p-values listed in Table 2 represent independent results, the 
single exception is rs1380304 for which data is represented for our follow-up, the non-
overlapping families in the GWAS, and the GWAS result itself. These preliminary findings 
further suggest that there may be a common variant within this region that is involved in 
MS.
Discussion
Despite the success of previous studies in narrowing the linkage peak on chromosome 1q43, 
the search for a susceptibility locus in this region remains a challenging task. Even in this 
narrowed interval there are over 20 known or predicted genes currently listed in the public 
databases, several of which could serve as candidate genes due to their proposed function 
(e.g. involvement in autoimmunity, viral susceptibility, oxidative stress/mitochondrial 
function, or neuronal processes) or due to their tissue expression patterns (Table 3). In 
addition, many of the remaining genes in this region have undergone little or no functional 
characterization, likely resulting in failure of these genes to be selected for investigation in a 
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candidate gene study despite their potential involvement in disease. These problems are not 
unique to studies of MS—studies of many complex diseases are hindered by flawed 
assumptions and lack of information concerning genes in a given candidate region. New 
methods that address these confounding factors are warranted. With this in mind we devised 
(and previously described) a process that prioritizes annotated SNPs for genotyping studies 
based on their location within Multi-species Conserved Sequences (MCSs) (Margulies, et al. 
2003) and used this process to select SNPs across this ~7.0 Mb region of interest 
(McCauley, et al. 2007).
The linkage signal in this region remains strong, although our results indicate that this 
appears to be independent of HLA status, a putative chromosome 2 locus, or the presence of 
multiple autoimmune disorders within a family. One possible explanation is that there may 
be multiple rare variants present in this region, leading to the consistent detection of linkage, 
but lending difficulties to detect strong association to a common variant.
Interestingly, the previous reports demonstrating linkage in the MS, rheumatoid arthritis, 
and systemic lupus erythematosus screens are within a few Mb of the peak SNP from the 
MSGG genomic screen and follow-up. However, genome-wide association studies (GWAS) 
across multiple autoimmune disorders have failed to convincingly identify common 
variation within this region predisposing to any or all of these autoimmune diseases. This is 
based on the current literature detailing the findings of these studies in numerous other 
autoimmune diseases. This does not exclude the possibility that the effects of common 
variation within this region are too small within these other diseases to be detected with the 
current available datasets. When examining the IMSGC GWAS results (International 
Multiple Sclerosis Genetics Consortium, et al. 2007) across this region, we find further 
potential evidence for association to SNPs within RGS7. Future examination of this region 
will undoubtedly require examination of copy-number variation (CNVs) and possible 
resequencing to identify a potential functional variant predisposing to MS.
Although the results of this study demonstrate some modest evidence for involvement of a 
common variant within the RGS7 gene to be associated with MS, additional well-powered 
studies need to be conducted in order to confirm these findings. RGS7 is a member of the 
family of proteins called regulators of G protein signaling (RGS) and it has been shown that 
altering RGS7 function could impair the normal dampening of the inflammatory response 
(Hausmann, et al. 2002). Hausmann and colleagues found that expression of RGS7 in 
microglia and/or invading peripheral macrophages was induced by the inflammatory 
response created by experimental spinal cord injury in rats. It may follow that impaired 
regulation of RGS7 expression may have detrimental effects on the normal inflammatory 
cascade and that these effects may play a role in multiple sclerosis.
Patients and Methods
Subjects and phenotypes
The dataset used for the first stage of this follow-up study consisted of 173 multiplex 
families with 405 total affected individuals (115 male, 290 female). Of these initial 
multiplex families, 91 families had previous evidence for positive linkage to 1q43 (Kenealy, 
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et al. 2006). The second stage (or extended) follow-up dataset included 831 multiplex and 
trio families with 1077 total affected individuals (266 male, 811 female). All families were 
ascertained at the University of California at San Francisco (UCSF) according to well 
established diagnostic and inclusion criteria.
All protocols were approved by the appropriate Institutional Review Boards and all 
individuals provided informed consent before participating in the study. Positive family 
histories were investigated by direct contact with other family members, request for medical 
records, and by clinical examination, laboratory testing, or paraclincial studies (MRI 
scanning and evoked-response testing). Individuals were placed into one of four categories: 
definite MS, probable MS, possible MS, and no evidence of MS. Consistent and stringent 
clinical criteria were applied as described elsewhere (Goodkin, et al. 1991, Haines, et al. 
1996) and all clinically definite MS cases met the Poser criteria (Poser, et al. 1983). Only 
definite MS cases were considered as affected in the analyses.
Molecular analysis
For the first stage of follow-up, 768 SNPs were genotyped across this region in 173 
multiplex families. The Illumina BeadArray™ platform was used for rapid and accurate 
SNP genotyping in our dataset. All genotyping was performed by the Duke Genomics 
Resource Laboratory Core using the Illumina BeadArray™ platform. This system provides 
automated outputs that ease transfer between data generation and the PEDIGENE® database 
system used in our statistical analyses (Haynes, et al. 1995). Due to our own SNP density 
requirements and the nature of the Illumina system, we chose 768 SNPs which completed 
two Illumina oligo pool assays (or OPAs). A detailed description of the SNP selection 
process for this project has been previously described ((McCauley, et al. 2007)). In general 
SNPs were selected by considering informativeness, validation status, location/density, and 
putative function. Average spacing of the 768 SNPs in the ~ 7.0 Mb region on 1q43–1q44 
region was < 10 kb— allowing for coverage of the region that is appropriate for observed 
patterns of linkage disequilibrium in Caucasian populations (Gabriel, et al. 2002). Most 
SNPs fell within intronic and intergenic areas.
We examined the Illumina panel of SNPs using standard measures of quality control, 
dropping 190 SNPs from downstream analysis. Of the 190 SNPs that failed: 167 SNPs were 
monomorphic in our dataset; 22 SNPs demonstrated poor assay performance as measured by 
call rate (<95%), cluster separation, or other assay failure; and 1 SNP mapped to multiple 
locations in the genome. For stage one of the follow-up, eleven samples were dropped 
(including 1 affected male, 3 affected females) due to low call rates (<95%) and an excess of 
Mendelian errors.
Subsequent to the initial linkage and association analysis of the 173 multiplex family 
dataset, more detailed association analysis was performed within the extended dataset of 831 
total families. SNPs, within the Illumina panel, demonstrating evidence for association as 
well as additional novel SNPs (n=51) within high priority regions based on linkage and 
association results were selected for further genotyping and analysis using Taqman assays 
from Applied Biosystems (Foster City, CA). The final set of the additional 51 SNPs met the 
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design criteria for Taqman, provided an additional level of marker density in key regions, 
and had relatively high minor allele frequencies.
Statistical analysis
Following completion of genotyping, quality control (QC) procedures were conducted to 
ensure the accuracy of all genotype data. These included SNP checks for call rate and assay 
reliability, as well as sample checks for call rate and Mendelian inconsistencies. Thresholds 
used to exclude data are discussed in the results.
After assessing the quality of both SNPs and samples, we conducted a battery of analyses to 
localize and identify common susceptibility variants underlying our narrowed linkage peak. 
Multipoint linkage analysis was performed using MERLIN (Abecasis, et al. 2002). Two-
point LOD scores were calculated in FASTLINK (Cottingham, et al. 1993, Schaffer, et al. 
1994), with two-point heterogeneity LOD (HLOD) scores being calculated through 
HOMOG (Ott. 1986). Ordered subset analyses (OSA) were performed using the FLOSS 
software (Browning. 2006). SNPs included in both multipoint linkage analysis and FLOSS 
were chosen using the implementation of Tagger within the Haploview software package 
(Barrett, et al. 2005, de Bakker, et al. 2005). Association analyses for this study were 
conducted using the PDT statistic (Martin, et al. 2000).
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Figure 1. Region of Interest on Chromosome 1q
Original multipoint calculations are represented by the solid curve. Multipoint calculations 
for an OSA subset identified by ranking families for “HLA Lod” scores (i.e. ranking 
families for inclusion in the multipoint analysis based on their lod scores at the peak linkage 
position from the HLA locus on chromosome 6) are represented by the dashed curve. 
Multipoint calculations for an OSA subset identified by ranking families for linkage to 
chromosome 2q35 are represented by the dotted curve. The cut-off corresponding to a -2.0 
LOD score confidence interval (from the ~3.8 lod of the HLA peak) is indicated by the 
horizontal line at ~1.8 and bordered by the intersection of this line with the original 
multipoint scores. This ~7 Mb interval is the target of our more detailed examination.
McCauley et al. Page 11
Genes Immun. Author manuscript; available in PMC 2010 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
McCauley et al. Page 12
Genes Immun. Author manuscript; available in PMC 2010 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. Multipoint Linkage Analyses across 1q43
These plots represent multipoint linkage across our narrowed region of interest on chr1q43. 
a) The original screen overlaid with multipoint linkage using the SNPs from the follow-up 
panel; additional examination of the HLA and chromosome 2 effects, as described in Figure 
1, again using the follow-up panel of SNPs b) Examining the evidence for linkage based on 
the presence or absence of multiple autoimmune disorders (AI) within a family.
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Table 1
Association Results
SNP NCBI Build 36.2 Minor Allele Frequency PDT (p-value) Gene Symbol
rs1933129 235,344,234 0.06 0.05 RYR2
rs2050656 235,577,537 0.15 0.02 RYR2
rs10925388 235,605,976 0.17 0.02 RYR2
rs632407 236,843,885 0.05 0.04
rs3738433 238,353,339 0.08 0.05 FMN2
rs6697953 239,521,130 0.27 0.03 RGS7
rs1053221 239,822,190 0.14 0.03 KMO
rs1053183 239,825,254 0.20 0.01 KMO/OPN3
rs6429302 239,979,931 0.16 0.04 WDR64
rs1342866 240,027,292 0.16 0.04 WDR64
rs3863747 240,543,878 0.24 0.03 PLD5
rs12032481 241,854,632 0.02 0.02 AKT3
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Table 3
Potential Functional Candidate Genes in the ~7 Mb region on chromosome 1q43
Gene Name/Protein Name Gene Symbol Tissue Expression Brief Description
cholinergic receptor, muscarinic 3 CHRM3 human brain role in neurogenesis
formin 2-like protein FMN2 human brain, spinal cord N/A
gremlin 2 / protein related to DAC and 
cerberus
PRDC human brain mapped to neurons and spinal cord in mouse; 
role in TGFβ signaling
regulator of G-protein signaling 7 RGS7 human brain upregulated in spinal cord injury; role in 
neuronal excitability
fumarate hydratase FH N/A mitochondrial precursor
kynurenine 3-monooxygenase KMO N/A role in oxidoreductase activity
opsin 3 (encephalopsin, panopsin) OPN3 human brain, spinal cord, 
thymus
N/A
choroideremia-like / Rab escort protein 2 CHML human thymus role in neurophysiology, regulation of 
balance
exonuclease 1 EXO1 human thymus role in DNA binding/repair, response to 
endogenous stimulus
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